Bill
A 1293
Bill A 1293 allows out-of-state medical cannabis patients to access their medication in New York, enhancing care and ensuring legal compliance while traveling.
Bill Number: A 1293
Title: Relates to reciprocity agreements with other states for medical cannabis programs
Status: Referred to Economic Development
Introduced: January 09, 2025
Classification: Bill
Bill A 1293 aims to establish a framework for reciprocity agreements between New York State and other states that have legalized medical cannabis programs. The intent of the bill is to facilitate access to medical cannabis for patients who are registered in their home state but may be traveling or residing temporarily in New York. This legislation seeks to enhance patient care and ensure that individuals with valid medical cannabis prescriptions can obtain their medication without legal complications.
Reciprocity Agreements: The bill authorizes the New York State Department of Health to enter into agreements with other states that have established medical cannabis programs. These agreements would allow patients from those states to access medical cannabis in New York.
Eligibility Criteria: The bill outlines specific criteria that must be met for patients to qualify for access under these agreements, including:
Regulatory Framework: The bill mandates the development of regulations to govern the implementation of these reciprocity agreements, ensuring that both patient safety and state compliance are prioritized.
Patients: Individuals with medical cannabis prescriptions from other states would benefit from increased access to their medication while in New York.
Healthcare Providers: Medical professionals in New York may see an increase in patients seeking consultations and prescriptions related to medical cannabis.
State Agencies: The New York State Department of Health will be responsible for managing the reciprocity agreements and ensuring compliance with state laws.
Legislative Action: The bill was introduced on January 09, 2025, and has been referred to the Economic Development Committee for further consideration.
Related Legislation: This bill is related to prior-session bills S 9218 and A 8321, as well as companion bill S 3105, indicating ongoing legislative interest in the topic of medical cannabis reciprocity.
Bill A 1293 represents a significant step towards enhancing the accessibility of medical cannabis for patients from other states. By establishing reciprocity agreements, the bill aims to create a more inclusive medical cannabis environment in New York, ultimately benefiting patients who rely on these services for their health and well-being. The bill is currently under review by the Economic Development Committee, and its progress will be closely monitored by stakeholders in the medical cannabis community.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
